ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates

scientific article published on February 15, 1992

ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9149(92)90982-5
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0002914992909825?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0002914992909825?httpAccept=text/xml
P698PubMed publication ID1736603

P2093author name stringF. S. Villanueva
W. H. Smith
G. A. Beller
D. D. Watson
P2860cites workThe safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study GroupQ28329296
Prevalence and correlates of increased lung/heart ratio of thallium-201 during dipyridamole stress imaging for suspected coronary artery diseaseQ30455273
Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery diseaseQ30460484
Non-invasive detection of coronary artery disease by body surface electrocardiographic mapping after dipyridamole infusionQ38592326
Conditions for vasodilator-induced coronary steal in experimental myocardial ischemiaQ41387569
Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarctionQ41430541
Angiographic findings in patients exhibiting ischemia after oral dipyridamoleQ42197541
Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X.Q42219388
Comparison of the electrocardiographic changes induced by dipyridamole infusion and treadmill exercise in patients with coronary artery diseaseQ42222996
Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolismQ42268589
The clinical and pathophysiologic implications of pain, ST abnormalities, and scintigraphic changes induced during dipyridamole infusion: their relationships to the peripheral hemodynamic responseQ46043355
Maximal treadmill exercise electrocardiography. Correlations with coronary arteriography and cardiac hemodynamics.Q51679270
Effect of nitroglycerin and dipyridamole on regional coronary resistance.Q54695129
Electrocardiographic changes suggestive of myocardial ischemia elicited by dipyridamole infusion in acute rejection early after heart transplantationQ58911683
Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exerciseQ68001041
Diagnostic value for coronary artery disease of chest pain during dipyridamole-thallium stress testingQ68253205
Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinantsQ68393289
ST segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patientsQ68842693
Ischemic ST-segment changes after dipyridamole infusionQ68961153
Noninvasive evaluation of cardiac risk before elective vascular surgeryQ69726370
Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgeryQ69864659
Regional blood flow correlates of ST segment depression in tachycardia-induced myocardial ischemiaQ69994589
Intrinsic washout rates of thallium-201 in normal and ischemic myocardium after dipyridamole-induced vasodilationQ70044059
Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motionQ70396747
Quantitative thallium-201 exercise scintigraphy for detection of coronary artery diseaseQ70832094
P433issue5
P407language of work or nameEnglishQ1860
P921main subjecthemodynamicsQ1642137
Cardiology and cardiovascular medicineQ96320350
P304page(s)445-8
P577publication date1992-02-15
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates
P478volume69

Reverse relations

cites work (P2860)
Q73041302ECG-manifest and ECG-silent dipyridamole technetium-99m sestamibi SPET perfusion defects in patients with ischaemic heart disease
Q48706631George Allan Beller, MD: a conversation with the editor. Interview by William Clifford Roberts
Q40673283Myocardial perfusion imaging during pharmacologic stress testing.
Q35031075Pharmacologic radionuclide myocardial perfusion imaging
Q33759396Pharmacological stress testing
Q43693237Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT.
Q44303970Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images
Q46423844QRS score versus ST-segment changes in patients undergoing Tl-201 scintigraphy using dipyridamole infusion
Q53473770Quantification of myocardial blood flow with 82Rb dynamic PET imaging.
Q47336822Results of adenosine single photon emission computed tomography thallium-201 imaging in hemodynamic nonresponders
Q48787870ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease
Q71027730Safety and efficacy of computerized closed-loop delivery of arbutamine: a new pharmacologic myocardial stress modality for the assessment of coronary artery disease. The European Arbutamine Study Group
Q42545776Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study
Q45003929Significance of myocardial ischemic electrocardiographic changes during dipyridamole stress echocardiography
Q36220637The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging
Q38759839The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging

Search more.